129 related articles for article (PubMed ID: 10718779)
41. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
[TBL] [Abstract][Full Text] [Related]
42. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome P4501A2 (CYP1A2) activity and lung cancer risk: a preliminary study among Chinese women in Singapore.
Seow A; Zhao B; Lee EJ; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee HP
Carcinogenesis; 2001 Apr; 22(4):673-7. PubMed ID: 11285205
[TBL] [Abstract][Full Text] [Related]
44. [Effect of Tibetan medicine zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2].
Li XY; Liu YN; Li YP; Zhu JB; Yao XC; Li YF; Yang M; Yuan M; Fan XR; Yin YM
Yao Xue Xue Bao; 2014 Feb; 49(2):267-72. PubMed ID: 24761621
[TBL] [Abstract][Full Text] [Related]
45. Salivary caffeine metabolic ratio in alcohol-dependent subjects.
Kukongviriyapan V; Senggunprai L; Prawan A; Gaysornsiri D; Kukongviriyapan U; Aiemsa-Ard J
Eur J Clin Pharmacol; 2004 Apr; 60(2):103-7. PubMed ID: 15022032
[TBL] [Abstract][Full Text] [Related]
46. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
[TBL] [Abstract][Full Text] [Related]
47. Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms--a Preliminary Case-control Study in Tunisia.
Imene A; Maurice AJ; Arij M; Sofia P; Saad S
Asian Pac J Cancer Prev; 2015; 16(8):3559-63. PubMed ID: 25921178
[TBL] [Abstract][Full Text] [Related]
48. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
[TBL] [Abstract][Full Text] [Related]
49. Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy.
Schnuch A; Westphal GA; Müller MM; Schulz TG; Geier J; Brasch J; Merk HF; Kawakubo Y; Richter G; Koch P; Fuchs T; Gutgesell T; Reich K; Gebhardt M; Becker D; Grabbe J; Szliska C; Aberer W; Hallier E
Contact Dermatitis; 1998 Apr; 38(4):209-11. PubMed ID: 9565293
[TBL] [Abstract][Full Text] [Related]
50. Role of metabolic polymorphisms NAT2 and CYP1A2 on urinary mutagenicity after a pan-fried hamburger meal.
Pavanello S; Simioli P; Mastrangelo G; Lupi S; Gabbani G; Gregorio P; Clonfero E
Food Chem Toxicol; 2002 Aug; 40(8):1139-44. PubMed ID: 12067576
[TBL] [Abstract][Full Text] [Related]
51. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.
Ozawa S; Katoh T; Inatomi H; Imai H; Kuroda Y; Ichiba M; Ohno Y
Int J Cancer; 2002 Dec; 102(4):418-21. PubMed ID: 12402313
[TBL] [Abstract][Full Text] [Related]
52. [Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics].
Pastera J; Anzenbacher P; Fiala Z
Acta Medica (Hradec Kralove) Suppl; 1999; 42(1):3-5. PubMed ID: 11253312
[TBL] [Abstract][Full Text] [Related]
53. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
[TBL] [Abstract][Full Text] [Related]
54. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
Pavanello S; Simioli P; Lupi S; Gregorio P; Clonfero E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):998-1003. PubMed ID: 12376499
[TBL] [Abstract][Full Text] [Related]
55. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
56. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow.
Sinués B; Sáenz MA; Lanuza J; Bernal ML; Fanlo A; Juste JL; Mayayo E
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):159-66. PubMed ID: 10067814
[TBL] [Abstract][Full Text] [Related]
57. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan.
Chiou HL; Wu MF; Chien WP; Cheng YW; Wong RH; Chen CY; Lin TS; Lee H
Cancer Lett; 2005 Jun; 223(1):93-101. PubMed ID: 15890241
[TBL] [Abstract][Full Text] [Related]
58. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
[TBL] [Abstract][Full Text] [Related]
59. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
60. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
